Interchange Capital Partners LLC Has $618,000 Stock Holdings in Intuitive Surgical, Inc. $ISRG

Interchange Capital Partners LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,138 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Interchange Capital Partners LLC’s holdings in Intuitive Surgical were worth $618,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in ISRG. Brighton Jones LLC lifted its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Intuitive Surgical by 9.3% during the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock worth $3,029,000 after purchasing an additional 518 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Intuitive Surgical by 0.3% during the 1st quarter. Sequoia Financial Advisors LLC now owns 8,587 shares of the medical equipment provider’s stock worth $4,253,000 after purchasing an additional 27 shares during the last quarter. Diversified Trust Co lifted its holdings in Intuitive Surgical by 23.2% during the 1st quarter. Diversified Trust Co now owns 5,401 shares of the medical equipment provider’s stock worth $2,675,000 after purchasing an additional 1,018 shares during the last quarter. Finally, Transcend Capital Advisors LLC lifted its holdings in Intuitive Surgical by 2.3% during the 1st quarter. Transcend Capital Advisors LLC now owns 2,696 shares of the medical equipment provider’s stock worth $1,335,000 after purchasing an additional 61 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $546.51 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market capitalization of $195.91 billion, a P/E ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61. The stock has a fifty day moving average of $458.09 and a 200-day moving average of $497.29.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the firm earned $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last three months. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a report on Tuesday. Jefferies Financial Group upped their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research report on Wednesday. Finally, Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $602.32.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.